VIVEbiotech is a CDMO specialized in the development and manufacture of research, preclinical toxicology and gmp-grade lentiviral vectors.

Visit VIVEbiotech Website >



Case study: Optimization of lentiviral vector production from early stages to GMP

  • LVV production requirements for scalability, regulatory compliance, and cost-effectiveness from early stages through to GMP.
  • How an optimized production process can be adapted to several intermediate scales, streamlining various developmental phases.
  • How to integrally manage LVV quality throughout the duration of the development project.
  • Quality being a key feature of suitability for the final product, we will also overview concepts of quality control and quality assurance.